CIK 0001570562
- Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 461385614
- Phone
- +1 949-284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- 4 Planned sale See Remarks sold 2,252 shares at $10.85 ($24,438)
- 4 Planned sale Chief Financial Officer sold 1,586 shares at $10.85 ($17,211)
- 4 Planned sale See Remarks sold 10,502 shares at $10.85 ($113,967)
- 4 Open-market sale Chief Financial Officer sold 3,276 shares at $14.98 ($49,074)
- 4 Open-market sale Chief Marketing Officer sold 5,631 shares at $15.85 ($89,251)
- 4 Grant or award Director acquired 23,014 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale See Remarks sold 471,432 shares at an average $12.74 ($6,005,628)
- 4 Open-market sale Director sold 7,500 shares at $12.96 ($97,203)
- 4 Open-market sale Director sold 10,361 shares at an average $12.64 ($131,010)
- 4 Open-market sale Director sold 28,000 shares at $12.93 ($362,012)
- 4 Open-market sale See Remarks sold 16,051 shares at $12.72 ($204,127)
- 4 Open-market sale See Remarks sold 3,441 shares at $12.72 ($43,761)
- 4 Open-market sale Chief Financial Officer sold 2,423 shares at $12.72 ($30,814)
- 4 Open-market sale See Remarks sold 6,236 shares at $13.86 ($86,431)
- 4 Open-market sale See Remarks sold 27,603 shares at $13.92 ($384,350)
- 4 Open-market sale Chief Financial Officer sold 5,672 shares at $13.92 ($78,978)
- 4 Open-market sale See Remarks sold 96,566 shares at $13.92 ($1,344,604)
- 4 Planned sale See Remarks sold 7,706 shares at $13.08 ($100,804)
- 4 Planned sale See Remarks sold 1,821 shares at $13.08 ($23,821)
Page 3 of 13 · 252 filings